•
Sep 30, 2023
The Joint Q3 2023 Earnings Report
Reported financial results for the third quarter of 2023.
Key Takeaways
The Joint Corp. reported revenue of $29.5 million for Q3 2023, compared to $26.5 million in Q3 2022. The company experienced an operating loss of $898,000, a net loss of $716,000, or $0.05 per share, and an adjusted EBITDA of $2.9 million.
Revenue increased to $29.5 million, compared to $26.5 million in the third quarter of 2022.
Operating loss was $898,000, compared to operating income of $732,000 in the third quarter of 2022.
Net loss was $716,000, or $0.05 per share, compared to income of $731,000 or $0.05 per share in the third quarter of 2022.
Adjusted EBITDA was $2.9 million, compared to $3.1 million in the third quarter of 2022.
The Joint
The Joint
Forward Guidance
Management has reiterated the financial and clinic opening guidance for 2023.